400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2200065390
尚未开始
/
/
/
2022-11-03
/
/
Substance abuse
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
To evaluate the effectiveness of a brief individual mindfulness training when added to smoking cessation treatment (i.e. nicotine replacement therapy + counseling) for preventing relapse in smoking compared to smoking cessation treatment only. Previous meta-analyses suggested having a more vigorous design in research on mindfulness training for smoking cessation (Maglione et al., 2017; Oikonomou et al., 2017). This study will be reported following the Consolidated Standards of Reporting Trials (CONSORT) standards (Schulz et al., 2010).
随机平行对照
Ⅰ期
The randomization table of each strata will be generated by an independent researcher via an online software.
none
未说明
/
45
/
2022-10-03
2024-10-03
/
1. Self-report daily smokers; 2. Receive nicotine patch treatment; 3. Motivated to quit within the next 30 days; 4. Aged >= 18 years; 5. Able to speak and read Chinese; 6. Not being pregnant.;
请登录查看1. Contraindication of nicotine patch use; 2. With significant physical illness or severe cognitive impairment that create obstacle for communication, such as blindness or severe hearing loss; 3. Actively psychotic or manic; 4. With active illicit drug use; 5. Alcohol dependence with Alcohol Use Disorders Identification Test (AUDIT) score 20 or above (World-Health-Organization, 2001); 6. Participation in mindfulness course or having daily mindfulness practice in the previous 12 months; 7. Participation in smoking cessation treatment in the previous 12 months.;
请登录查看Prince of Wales Hospital
/
AI 西宝生物2026-06-04
天勤生物Topgene2026-06-04
生物技术小编2026-06-04
杏泽资本2026-06-04
医药笔记2026-06-04
医药笔记2026-06-04
药明康德2026-06-04
医麦客2026-06-04
生物制品圈2026-06-03
ADC InsightsOnline2026-06-03